Trilogy Capital’s Texas Instruments TXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Sell
841
-15,996
-95% -$4.44M 0.01% 361
2026
Q1
$3.27M Sell
16,837
-309
-2% -$62.6K 0.14% 114
2025
Q4
$2.97M Buy
17,146
+1,901
+12% +$326K 0.13% 131
2025
Q3
$2.8M Sell
15,245
-649
-4% -$127K 0.13% 122
2025
Q2
$3.3M Sell
15,894
-369
-2% -$65.5K 0.16% 92
2025
Q1
$2.92M Buy
16,263
+247
+2% +$46.2K 0.15% 95
2024
Q4
$3M Buy
16,016
+395
+3% +$79K 0.15% 100
2024
Q3
$3.23M Sell
15,621
-440
-3% -$88.4K 0.16% 102
2024
Q2
$3.12M Buy
16,061
+364
+2% +$67.3K 0.17% 96
2024
Q1
$2.73M Buy
+15,697
New +$2.62M 0.16% 116
2018
Q4
Sell
-25
Closed -$3K 528
2018
Q3
$3K Hold
25
﹤0.01% 469
2018
Q2
$3K Hold
25
﹤0.01% 428
2018
Q1
$3K Buy
+25
New +$2.71K ﹤0.01% 361

Other funds holding TXN

Trilogy Capital's TXN Position: Q2 2026 in Review

Trilogy Capital reduced its Texas Instruments (TXN) stake by 95% in Q2 2026, selling an estimated $4.44M and leaving 841 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #361.

Trilogy Capital first reported a position in TXN in Q1 2018 and has held it in 13 quarters since. The position peaked at $3.3M in Q2 2025. 2,843 funds tracked by Wall St. Rank hold TXN as of Q2 2026.

  • Trilogy Capital held 841 shares of Texas Instruments worth $251K as of Q2 2026.
  • Trilogy Capital sold 15,996 Texas Instruments shares in Q2 2026, an estimated $4.44M.
  • Texas Instruments made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #361 holding.
  • Trilogy Capital first reported a position in Texas Instruments in Q1 2018 and has held it in 13 quarters since.
  • Trilogy Capital's Texas Instruments position peaked at $3.3M in Q2 2025.
  • 2,843 funds tracked by Wall St. Rank held Texas Instruments as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.